(FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 21.27%166.62B | 26.52%119.42B | 32.65%77.76B | 34.28%36.73B | 31.24%137.4B | 27.18%94.39B | 20.94%58.62B | 22.04%27.35B | 42.68%104.69B | 49.92%74.22B |
Operating income | 21.27%166.62B | 26.52%119.42B | 32.65%77.76B | 34.28%36.73B | 31.24%137.4B | 27.18%94.39B | 20.94%58.62B | 22.04%27.35B | 42.68%104.69B | 49.92%74.22B |
Cost of sales | -20.93%-153.94B | -26.09%-111.09B | -32.27%-72.73B | -35.54%-35.09B | -28.71%-127.3B | -23.78%-88.11B | -17.74%-54.99B | -16.73%-25.89B | -47.45%-98.91B | -61.45%-71.18B |
Operating expenses | -20.93%-153.94B | -26.09%-111.09B | -32.27%-72.73B | -35.54%-35.09B | -28.71%-127.3B | -23.78%-88.11B | -17.74%-54.99B | -16.73%-25.89B | -47.45%-98.91B | -61.45%-71.18B |
Gross profit | 25.58%12.68B | 32.57%8.33B | 38.39%5.03B | 11.93%1.64B | 74.61%10.1B | 106.74%6.28B | 105.40%3.63B | 533.48%1.46B | -8.10%5.78B | -43.91%3.04B |
Selling expenses | -23.06%-5B | -28.56%-3.71B | -23.67%-2.35B | -20.04%-1.14B | -31.96%-4.06B | -31.52%-2.88B | -37.84%-1.9B | -42.71%-951.05M | -69.54%-3.08B | -101.75%-2.19B |
Administrative expenses | -6.21%-3.35B | -13.55%-2.48B | -28.54%-1.68B | -38.90%-891.12M | -10.11%-3.16B | 3.12%-2.19B | 13.87%-1.3B | 21.40%-641.55M | -70.78%-2.87B | -55.32%-2.26B |
Research and development expenses | -14.36%-3.57B | -20.65%-2.69B | -26.88%-1.82B | -21.53%-903.77M | -11.00%-3.12B | -6.10%-2.23B | -4.28%-1.44B | -9.39%-743.64M | -36.95%-2.81B | -45.75%-2.1B |
Revaluation surplus | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -164.22%-12.84B | -725.19%-12.84B |
-Changes in the fair value of other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -164.22%-12.84B | -725.19%-12.84B |
Impairment and provision | 13.44%-251.56M | -57.67%-140.14M | -57.67%-140.14M | ---- | -86.46%-290.62M | -210.97%-88.89M | -210.97%-88.89M | ---- | 29.49%-155.86M | 82.71%-28.58M |
-Other impairment is provision | 13.44%-251.56M | -57.67%-140.14M | -57.67%-140.14M | ---- | -86.46%-290.62M | -210.97%-88.89M | -210.97%-88.89M | ---- | 29.49%-155.86M | 82.71%-28.58M |
Operating interest expense | -16.05%-1.04B | -32.62%-541.63M | -32.62%-541.63M | ---- | -24.27%-893.32M | -15.83%-408.4M | -15.83%-408.4M | ---- | -58.07%-718.85M | -11.98%-352.6M |
Special items of operating profit | 240.85%2.13B | 1,398.96%1.44B | 462.96%1.12B | ---- | -44.66%625.25M | -81.91%95.99M | -66.00%198.47M | ---- | 39.99%1.13B | -13.01%530.63M |
Operating profit | 300.10%1.6B | 114.36%203.97M | 70.37%-387.69M | -48.69%-1.3B | 94.85%-801.14M | 91.24%-1.42B | 91.36%-1.31B | 54.71%-874.87M | -290.53%-15.56B | -190,076.03%-16.21B |
Share of profits of associates | 221.62%15.85M | 138.23%5.48M | 138.23%5.48M | ---- | 64.55%-13.04M | 13.72%-14.32M | 13.72%-14.32M | ---- | 42.61%-36.77M | -36.83%-16.6M |
Special items of earning before tax | ---- | ---- | ---- | 167.66%287.84M | ---- | ---- | ---- | 95.28%-425.4M | ---- | ---- |
Earning before tax | 298.84%1.62B | 114.60%209.44M | 71.11%-382.21M | 22.10%-1.01B | 94.78%-814.18M | 91.16%-1.43B | 91.28%-1.32B | 88.13%-1.3B | -285.26%-15.6B | -450,854.78%-16.23B |
Tax | -63.60%-451.72M | -92.59%-284.02M | -32.45%-146.66M | 52.13%-23.86M | -357.34%-276.11M | -269.95%-147.48M | -109.67%-110.73M | -5.13%-49.84M | -602.82%-60.37M | -391.18%-39.86M |
After-tax profit from continuing operations | 207.05%1.17B | 95.29%-74.57M | 63.11%-528.87M | 23.20%-1.04B | 93.04%-1.09B | 90.27%-1.58B | 90.58%-1.43B | 87.73%-1.35B | -287.90%-15.66B | -138,752.80%-16.27B |
Earning after tax | 207.05%1.17B | 95.29%-74.57M | 63.11%-528.87M | 23.20%-1.04B | 93.04%-1.09B | 90.27%-1.58B | 90.58%-1.43B | 87.73%-1.35B | -287.90%-15.66B | -138,752.80%-16.27B |
Minority profit | 79.75%551M | 108.31%348.33M | 279.33%108.34M | -234.66%-47.95M | 69.15%306.54M | 1.36%167.22M | -80.50%28.56M | -48.31%35.61M | 87.40%181.23M | 177.22%164.98M |
Profit attributable to shareholders | 144.11%616.19M | 75.83%-422.91M | 56.42%-637.21M | 28.64%-988.88M | 91.18%-1.4B | 89.35%-1.75B | 90.48%-1.46B | 87.48%-1.39B | -283.21%-15.84B | -22,967.69%-16.43B |
Basic earnings per share | 143.48%0.1 | 60.00%-0.1 | 92.79%-0.23 | 93.09%-0.25 | -203.81%-3.19 | |||||
Diluted earnings per share | 143.48%0.1 | 60.00%-0.1 | 92.79%-0.23 | 93.09%-0.25 | -203.81%-3.19 | |||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
Auditor | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | -- | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- | -- | -- | Deloitte & Touche Tohmatsu Certified Public Accountants | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data